
A leading provider of
innovative DNA Screening solutions
Some cases of CML have constitutive activation of the gene for PDGFRβ which encodes a receptor for tyrosine kinase. The activation is usually caused by a t(5;12)(q32;p13) translocation which results in the ETV6-PDGFRβ fusion gene. The drug imatinib mesylate (Gleevec) specifically inhibits the kinase activity of PDGFRβ and has shown efficiency in the treatment of chronic myeloid leukaemia and gastrointestinal stromal tumours.
Cat. No. LPH 031-S (5 tests)
Cat. No. LPH 031 (10 tests)
These products are only available labelled as Analyte Specific Reagents (ASR) in the USA.
Developed &